Overview of the management of HER2-low breast cancer patients

A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer

Clinical and molecular characteristics of HER2-low/zero early stage triple-negative breast cancer

Is HER2-low a distinct subtype of breast cancer?

HER2-low breast cancer: the ESMO Expert Consensus Statements

The exciting new field of HER2-low breast cancer

Remaining questions on the management of HER2-low breast cancer

What is HER2 low in breast cancer?

HER2-Low Breast Cancer: DESTINY or Good Science?

Latest news in HER2-low breast cancer

Genomic and transcriptomic landscape of HER2-low breast cancer

Biological behaviour of HER2-low BC is dependent on HR expression

Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate

Findings indicate HER2-low and HER2-negative breast cancer are biology indistinct

HER2-Low Expression in Breast Cancer: Opportunities for Expanding Treatment Benefit to More Patients

HER2 Positive, Negative or Low? Breast Cancer Updates in 2023

ADCs for the treatment of HER2-low breast cancer

HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review Conference

HER2-low status as a therapeutic target in advanced breast cancer

What is HER2 Testing in Breast Cancer? | Dr Kiley Loh